Release Date: 06/05/16 16:10 Summary: Ceasing to be a substantial holder-BRS.AX Price Sensitive: No Download Document 63.15KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%